PHILADELPHIA – A team of cardiologists, materials scientists, and bioengineers have created and tested a new type of implantable device for measuring the heart’s electrical output that they say is a vast improvement over current devices. The new device represents the first use of flexible silicon technology for a medical application.
Health & Medicine
PHILADELPHIA – Psychologists led by the University of Pennsylvania have used implantable electrodes and a first-person driving game to identify the cells of the brain that indicate travel in a clockwise or counterclockwise motion, called “path cells.” The study will be published this week in the Proceedings of the National Academy of Sciences.
Double Agents: Penn Researchers Identify Immune Cells That Fight Parasites May Promote Allergies and Asthma
PHILADELPHIA –- Millions of people in both the developing and developed world may benefit from new immune-system research findings from the University of Pennsylvania School of Veterinary Medicine.
The Penn Vet researchers, studying how the immune system operates, have discovered a previously unidentified cell population that may be the body’s double-edged sword, fighting off parasitic infections but also causing the harmful immune responses that can lead to allergies and asthma.
MEDIA ADVISORY & PHOTO OPPORTUNITY
Media Contact:Jill DiSanto-Haines | firstname.lastname@example.org | 215-898-4820February 24, 2010
Penn Nursing Hosts "Cities and Women’s Health: Global Perspectives" to Tackle Modern Urban Health Issues
PHILADELPHIA –- Biologists at the University of Pennsylvania studying oocytes in mice, the immature egg cells necessary for sexual reproduction, have demonstrated an unusual behavior in microRNA, or miRNA, activity that may be the first event in reprogramming the differentiated oocyte into pluripotent blastomeres of the embryo. MicroRNAs are a member of the family of small RNAs, the so-called dark matter of the biological world.
Penn Study Shows Antidepressants Work Best for Severe Depression, Provide Little to No Benefit Otherwise
PHILADELPHIA –- A study of 30 years of antidepressant-drug treatment data published today in the Journal of the American Medical Association shows that the benefit of antidepressant medication compared with placebo may be minimal or nonexistent in patients with mild or moderate symptoms. University of Pennsylvania researchers say, however, the benefit of medications is substantial for patients with very severe depression.